Development and validation of the HPLC method for varenicline determination in pharmaceutical preparation

1. Carpenter MJ et al.: Clinical Strategies to Enhance the Efficacy of Nicotine Replacement Therapy for Smoking Cessation: A Review of the Literature. Drugs., 73, 407, 2013.10.1007/s40265-013-0038-y366202423572407Search in Google Scholar

2. Stead L.F. et al.: Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews., 11, CD000146, 2012.10.1002/14651858.CD000146.pub423152200Search in Google Scholar

3. Jiloha R.C.: Biological basis of tobacco addiction: Implications for smoking-cessation treatment. Indian J Psychiatry., 52, 301, 2010.10.4103/0019-5545.74303302515421267362Search in Google Scholar

4. Wilkes S.: The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis., 3, 45, 2008.10.2147/COPD.S1121Search in Google Scholar

5. Zatonski W. et al.: An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control., 15, 481, 2006.10.1136/tc.2006.016097256368217130378Open DOISearch in Google Scholar

6. Coe J.W. et al.: Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem., 48, 3474, 2005.10.1021/jm050069n15887955Open DOISearch in Google Scholar

7. Balaji M. et al.: Development and validation of related substances method for Varenicline and its impurities. Der Pharmacia Lettre., 8, 304, 2016.Search in Google Scholar

8. Pujeri S.S., Khader A.M., Seetharamappa J.: Stress degradation studies on varenicline tartrate and development of a validated stability-indicating HPLC method. Sci Pharm., 80, 115, 2012.Search in Google Scholar

9. Kadi A.A. et al.: A validated stability-indicating HPLC method for determination of varenicline in its bulk and tablets. Chemistry Central Journal., 5, 30, 2011.10.1186/1752-153X-5-30313353521672253Search in Google Scholar

10. Satheesh B., Sree Ganesh K.K., Saravanan D.: Identification, isolation and characterization of an unknown impurity of varenicline. Sci Pharm., 80, 329, 2012.Search in Google Scholar

11. Channabasavaraj K.P., Modiya J.S., Sharath H.M.: Development and validation of RP-HPLC method for estimation of Varenicline tartrate in bulk drug and tablet dosage form. Int J Pharm Pharm Sci., 3, 59, 2011.Search in Google Scholar

12. El-Bagary R.I., Abo-Talib N.F., Mohamed M.A.: Novel liquid chromatographic methods for the determination of varenicline tartrate. Talanta., 146, 83, 2016.Search in Google Scholar

13. Dobrinas M. et al.: Quantification of nicotine, cotinine, trans-3’- hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation. J Chromatogr B Analyt Technol Biomed Life Sci., 879, 3574, 2011.Search in Google Scholar

14. Al-Haj A. et al.: Method development, validation and bioequivalence of varenicline in human plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci., 931, 134, 2013.Search in Google Scholar

15. Koçak E., Çelebier M., Altinöz S.: Validation of Spectrophotometric Method to Quantify Veranicline Content in Tablets. Asian J. Chem., 25, 1845, 2013.Search in Google Scholar

16. Kassem M.G., Darwish I.A., Darwish H.W.: Highly sensitive fluorimetric method for determination of varenicline in its bulk and tablets via derivatization with 7-chloro-4-nitrobenzoxadiazole. Digest Journal of Nanomaterials and Biostructures., 9, 1065, 2014.Search in Google Scholar

17. ICH Guideline: Q2(R1). Validation of Analytical Procedure: Text and Methodology. ICH, London. 2005.Search in Google Scholar